Mediclin AG Stock
Mediclin AG Stock
There is an upward development for Mediclin AG compared to yesterday, with an increase of €0.040 (1.120%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Mediclin AG stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Mediclin AG in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Mediclin AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Mediclin AG | 1.120% | 2.299% | 1.714% | 20.270% | -0.559% | 17.881% | -20.536% |
| Vita 34 AG | 1.350% | -1.336% | -5.342% | 13.590% | -27.377% | -37.955% | -73.552% |
| M1 Kliniken AG | 1.970% | 5.515% | 12.992% | 10.954% | -10.313% | 131.452% | 61.690% |
| Healthstream Inc. | 13.810% | 3.279% | 8.000% | -36.149% | -3.077% | -12.500% | -11.682% |
News
EQS-News: MEDICLIN increases group operating result in the first quarter
EQS-News: MEDICLIN increases group operating result in the first quarter
EQS-News: MEDICLIN lays a solid foundation for further growth with its 2025 financial results
EQS-News: MEDICLIN lays a solid foundation for further growth with its 2025 financial results
EQS-News: MEDICLIN invites you to the 2026 virtual press conference on the financial statements for the year 2025
EQS-News: MEDICLIN invites you to the 2026 virtual press conference on the financial statements for the year 2025